Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American … – MarketWatch (press release)

Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American
MarketWatch (press release)
5, during the American College of Allergy, Asthma and Immunology annual meeting in Boston. "In addition to a reduced rate of serious bacterial infections, the phase III study data suggest potentially useful attributes of HyQ, such as the possibility

and more »

View full post on asthma – Google News

Teva Presents New Data on QNASL(TM) at the 2011 American College of Allergy … – MarketWatch (press release)

Teva Presents New Data on QNASL(TM) at the 2011 American College of Allergy
MarketWatch (press release)
In addition, the presence of co-morbidities such as asthma and sinusitis further increase AR-related treatment costs. QNASL(TM) is an investigational intranasal corticosteroid in development for the treatment of allergic rhinitis symptoms.
Teva Presents New Data On QNASL™ At The 2011 American College Of Allergy TheStreet.com (press release)

all 13 news articles »

View full post on asthma – Google News

IBM, Georgia Tech Point Data Modeling At Kids Health – InformationWeek

IBM, Georgia Tech Point Data Modeling At Kids Health
InformationWeek
Project seeks to identify factors contributing to health outcomes of pediatric patients with asthma, autism, and diabetes. By Marianne Kolbasuk McGee InformationWeek IBM and the Georgia Institute of Technology are launching a new data analysis and
IBM and Georgia Institute of Technology Partner on "One Million Healthy PR Newswire (press release)
IBM, Georgia Institute of Technology form pediatric data partnershipZDNet (blog)

all 17 news articles »

View full post on asthma – Google News

IBM, Georgia Institute of Technology form pediatric data partnership – ZDNet (blog)

IBM, Georgia Institute of Technology form pediatric data partnership
ZDNet (blog)
This effort, dubbed One Million Healthy Children, will focus on children with diabetes, asthma and autism fist. The project includes Emory University, Children's Healthcare of Atlanta, Georgia Cancer Coalition and the Georgia Department of Community
IBM and Georgia Institute of Technology Partner on "One Million Healthy PR Newswire (press release)

all 11 news articles »

View full post on asthma – Google News

Boston Scientific Shows Upbeat Data – Daily Markets

Boston Scientific Shows Upbeat Data
Daily Markets
Leading medical devices player Boston Scientific (NYSE:BSX) presented positive data from the Research in Severe Asthma (RISA) trial at a conference in Amsterdam. It was observed that patients with severe refractory asthma, when treated with Alair
Boston Scientific begins enrolment for nerve stimulation trialZenopa

all 2 news articles »

View full post on asthma – Google News

Clinical Data Demonstrates Long-Term Safety of Boston Scientific’s Alair[TM … – MarketWatch (press release)

Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM
MarketWatch (press release)
Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European
Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM Genetic Engineering News

all 6 news articles »

View full post on asthma – Google News

Fifty years of pediatric asthma in developed countries: How reliable are the basic data sources?

Fifty years of pediatric asthma in developed countries: How reliable are the basic data sources?

Pediatr Pulmonol. 2011 Sep 8;

Authors: Chawla J, Seear M, Zhang T, Smith A, Carleton B

Abstract
Given the difficulties in diagnosing, or even defining, asthma in children, claims of a pediatric asthma epidemic in Canada and other developed countries are accepted with surprisingly little critical examination. We reviewed a broad range of data sources to understand how the epidemic evolved during the last 50 years and also to assess the reliability of the conclusions drawn from that data. We obtained Canadian National and Provincial data from Statistics Canada National Population Health Survey, and the British Columbia Ministry of Health respiratory database. International data were obtained by extensive review of pediatric asthma epidemiological surveys published during the last 50 years. In many developed countries, there have been three separate epidemics involving different aspects of pediatric asthma during the last 50 years: a double peaked mortality epidemic (1960s and 1980s), a hospital admission epidemic (peaked around 1990) and a steadily growing epidemic of children who report asthmatic symptoms on questionnaires. Canadian pediatric rates for asthma mortality (1-2/million/year) and hospital admission (1-2/thousand/year) are low and have fallen for the last 20 years. Rates based on questionnaire studies are high (10-15/hundred) and rose steadily over the same period. Objective reductions in asthma deaths and hospital admission likely reflect improved education and treatment programmes. Current claims of an epidemic based largely on subjective self-reported symptoms require more careful analysis. The possibility that symptom misperception, disease fashions, and poor recall, may be part of the explanation for the current high levels of self-reported symptoms deserves more attention. Pediatr Pulmonol. © 2011 Wiley-Liss, Inc.

PMID: 21905263 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Data for Houston region find higher asthma hospitalization rate in rural areas – Houston Chronicle


Houston Chronicle

Data for Houston region find higher asthma hospitalization rate in rural areas
Houston Chronicle
Janczak said she and her children suffer from asthma and find access to a doctor difficult. • Stay away from things that trigger an attack. • Follow the medicine instructions of your health care provider. From Dana Janczak's home in a secluded rural

View full post on asthma – Google News